Home Private Equity News & Analysis

Private Equity News & Analysis

Multiple speech bubbles containing dollar signs against a green background
Using NAV loans for add-on acquisitions is the most acceptable circumstance to investors, according to Coller Capital's latest Global Private Capital Barometer.
Head of The Carlyle Group’s Global Investment Solutions Ruulke Bagijn and Managing Director, Global Head of Primary Fund, Wendy Zhu
AlpInvest chair Ruulke Bagijn and global head of primaries Wendy Zhu tell PEI that the Carlyle secondaries unit is seeing higher quality LP-led opportunities come to market.
GBP banknotes
UK voters could find out more details about proposals to tax carried interest at the higher rate this week. Plus: Summit Partners' $9bn target; and promising signs for wealth and HNWI capital. Here's today's brief, for our valued subscribers only.
PEI spotlight
In this podcast, PEI's Adam Le, Hannah Zhang and Alex Lynn discuss which firms made this year's ranking and what this says about the state of private equity fundraising.
Dollar valve on the pipeline
Two intermediaries in the NAV loan market have published surveys on LPs' views of such loans. Plus: why AI could be one of the biggest threats to your firm. Here's today's brief, for our valued subscribers only.
Headshot of Juan Delgado-Moreira, co-CEO of Hamilton Lane, against a purple background
The firm asks GPs to ensure the limited partner advisory committee is consulted on the use of NAV facilities, co-chief executive Juan Delgado-Moreira tells PEI.
The Court's decision hands a big victory to private fund managers while rifts in the LP community may have aided the downfall of the regulatory package.
Altamar CAM CEO José Luis Molina
Separately managed accounts create 'solutions for headaches that people have', AltamarCAM CEO José Luis Molina tells PEI.
Continuation funds should create value, but how quickly? Plus: Nordic's 4x; and a look at some of the biggest secondaries funds in market. Here's today's brief, for our valued subscribers only.
Three large vials and one small vial
The firm has set a €400m hard-cap for ArchiMed MED Rise, according to documents prepared by a US pension.

Copyright PEI Media

Not for publication, email or dissemination